Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Northland Biotech. Co., Ltd.

Clinical trials sponsored by Beijing Northland Biotech. Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to heal hearts after major attack Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug aims to heal hearts after major attack

Disease control Not yet recruiting

This study tests a drug called NL005 in people who have had a severe type of heart attack (STEMI) and undergone emergency artery-opening treatment. The goal is to see if NL005 can reduce permanent heart muscle damage. Participants will receive either NL005 or a placebo daily for …

Phase 2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC